Lumos Diagnostics Holdings Limited (ASX:LDX)
0.0730
+0.0020 (2.82%)
Nov 17, 2026, 10:53 AM AEDT
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 70.93 million as of November 16, 2026. It is the 30,593rd most valuable company in the world and the 689th biggest in Australia. Its market cap has decreased by 54.95% in one year.
Market Cap
70.93M
Enterprise Value
57.22M
Revenue
19.07M
Global Rank
Country Rank
#689 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 70.93M, a decrease of -63.94%. That is a compound annual growth rate of -17.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 70.93M | -68.38% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 134.32M |
| EBR Systems | 131.05M |
| SomnoMed | 68.13M |
| Cyclopharm | 59.98M |
| Epiminder | 59.58M |
| Saluda Medical | 49.14M |
| Compumedics | 46.94M |
| Nova Eye Medical | 45.59M |